Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Molecular Medicine (Cambridge, Mass.)|August 10, 2012
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infectionSamantha J Westrop, Graeme Moyle, Akil Jackson, et al.
Journal of Medical Virology|February 26, 2008
Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugsCarlo-Federico Perno, Graeme Moyle, Chris Tsoukas, et al.
AIDS Patient Care and Stds|May 16, 2008
Potential for new antiretrovirals to address unmet needs in the management of HIV-1 infectionGraeme Moyle, Jose Gatell, Carlo-Federico Perno, et al.
Journal of the International AIDS Society|November 15, 2014
Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitorsTristan J Barber, Graeme Moyle, Andrew Hill, et al.
AIDS (London, England)|July 2, 2005
Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trialDesmond Maitland, Graeme Moyle, James Hand, et al.
BMJ Case Reports|April 21, 2021
Tale of two viruses: parvovirus B19 and HIVHayley Hernstadt, Paul Randell, Sarah Fidler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control studyRachael Jones, Justin Stebbing, Mark Nelson, et al.
AIDS Research and Human Retroviruses|October 15, 2021
Short Communication: Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIVBranca Pereira, Maria Mazzitelli, Ana Milinkovic, et al.
Pageof 14